3 11, 2021 Caterina De Luca et. al., RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer. Diatech Pharmacogenetics2021-11-03T17:22:10+01:00 Read More
25 08, 2021 Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Diatech Pharmacogenetics2021-08-25T12:02:27+02:00 Read More
6 01, 2021 Elena Lastraioli et. al., KRAS and NRAS mutation detection in circulating DNA from patients with metastatic colorectal cancer using BEAMing assay: Concordance with standard biopsy and clinical evaluation Diatech Pharmacogenetics2021-11-03T17:07:30+01:00 Read More
29 12, 2020 Vincenzo Formica et. al., Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients—The Importance of Tissue/Plasma Discordant Cases Diatech Pharmacogenetics2020-12-29T11:28:18+01:00 Read More
7 12, 2020 Annamaria Siggillino et. al., Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR. Diatech Pharmacogenetics2020-12-07T16:31:14+01:00 Read More
7 12, 2020 Annamaria Siggillino et. al., Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR Diatech Pharmacogenetics2020-12-07T12:32:21+01:00 Read More
